Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Định dạng: PDF / Số trang: 7
Các file có chung chủ đề
Case Law and Variations in Cumulative Impact Productivity Claims
